$BIO protocol enables the creation of BioDAOs. Researchers working on peptides can raise funds through these community based structures instead of your traditional funding systems.
In terms of TA, price has shown some strength/trend break in a very long time. So instead of fading this, one can get behind it by bidding the retest into EMAs for a possible move towards $0.1.
Invalidation in this case would be price breaking below the EMAs
